Effects of LGD1069 on Blood Vessel Formation in Cancer
Author Information
Author(s): Fu Jianjiang, Wang Wei, Liu Yu-Hui, Lu Hong, Luo Yongming
Primary Institution: Jiangxi University of Traditional Chinese Medicine
Hypothesis
Does LGD1069 inhibit angiogenesis and metastasis in human endothelial cells?
Conclusion
LGD1069 may impair the ability of tumor cells to promote blood vessel formation and metastasis by suppressing Runx2 expression in human endothelial cells.
Supporting Evidence
- LGD1069 inhibited the proliferation, adhesion, invasion, and migration of endothelial cells.
- Runx2 expression was significantly suppressed during incubation with LGD1069.
- LGD1069 decreased the expression of matrix metalloproteinases (MMP-2 and MMP-9) in endothelial cells.
Takeaway
LGD1069 is a medicine that helps stop cancer from spreading by blocking the growth of blood vessels that feed tumors.
Methodology
The study used human umbilical vein endothelial cells (HUVECs) and various assays to measure cell viability, migration, invasion, and gene expression.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Participant Demographics
Human umbilical vein endothelial cells were used, but specific demographics of donors were not detailed.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website